FDA approves second OTC naloxone spray for suspected opioid overdose
The U.S. Food and Drug Administration has approved RiVive, an over-the-counter (OTC) naloxone hydrochloride nasal spray for emergency treatment of known or suspected opioid overdose.
Aug 4, 2023
0
10
